Overview

Esmolol Versus Dexmedetomidine During Intracranial Procedures

Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Patients undergoing intracranial procedures may experience severe hypertension and tachycardia due to intracranial hypertension and to increased release of adrenaline. Preventing perioperative sympathetic activity is of great importance. A common technique is using b-blockers like esmolol, which effectively block perioperative hemodynamic changes during intracranial surgery. A2 agonists, like Dexmedetomidine-Dex are now being used as a component of a balanced anesthesia during neurosurgical procedures. This study aimed to evaluate whether esmolol or dex attenuates perioperative changes in patients undergoing elective craniotomy with fast track neuroanesthesia.
Phase:
Phase 3
Details
Lead Sponsor:
George Papanicolaou Hospital
Treatments:
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Adrenergic Antagonists
Dexmedetomidine
Esmolol